X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (27) 27
oncology (18) 18
female (17) 17
male (17) 17
middle aged (15) 15
aged (14) 14
index medicus (14) 14
adult (13) 13
cancer (10) 10
aged, 80 and over (8) 8
hematology (8) 8
medicine, research & experimental (7) 7
cell biology (6) 6
melanoma (6) 6
telomerase - metabolism (6) 6
animals (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
chemotherapy (5) 5
disease-free survival (5) 5
medicine & public health (5) 5
medicine, general & internal (5) 5
metastasis (5) 5
analysis (4) 4
cancer therapies (4) 4
care and treatment (4) 4
clinical trials (4) 4
dermatology (4) 4
disease progression (4) 4
expression (4) 4
homologous recombination (4) 4
lymphomas (4) 4
maintenance (4) 4
metastases (4) 4
prognosis (4) 4
quality of life (4) 4
skin neoplasms - pathology (4) 4
survival (4) 4
survival rate (4) 4
targeted therapy (4) 4
antimitotic agents (3) 3
antineoplastic agents (3) 3
biochemistry & molecular biology (3) 3
cd44 (3) 3
cell line (3) 3
classification (3) 3
dabrafenib (3) 3
dna (3) 3
dosage and administration (3) 3
drug therapy (3) 3
elongation (3) 3
genes (3) 3
genetic aspects (3) 3
health aspects (3) 3
immortalization (3) 3
immunohistochemistry (3) 3
lymphoma (3) 3
mammalian-cells (3) 3
medical research (3) 3
melanoma - drug therapy (3) 3
melanoma - pathology (3) 3
mice (3) 3
mutation (3) 3
non-hodgkins-lymphoma (3) 3
pathway (3) 3
recombination, genetic (3) 3
retrospective studies (3) 3
safety (3) 3
skin neoplasms - drug therapy (3) 3
sunitinib (3) 3
telomere - genetics (3) 3
trametinib (3) 3
vemurafenib (3) 3
young adult (3) 3
abridged index medicus (2) 2
adhesion molecules (2) 2
adjuvant (2) 2
adolescent (2) 2
alt (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antibodies, monoclonal - adverse effects (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
article (2) 2
b-cll (2) 2
belgium - epidemiology (2) 2
bone marrow transplantation (2) 2
bone neoplasms - drug therapy (2) 2
bone neoplasms - secondary (2) 2
braf inhibitor (2) 2
calcium (2) 2
catalytic subunit gene (2) 2
cell line, tumor (2) 2
chronic lymphocytic-leukemia (2) 2
chronic myelogenous leukemia (2) 2
cisplatin (2) 2
clone cells (2) 2
complications and side effects (2) 2
cyclophosphamide (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 14, pp. 1345 - 1356
Journal Article
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, ISSN 1542-3565, 02/2019
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 390, Issue 10094, pp. 555 - 566
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 7/2016, Volume 78, Issue 1, pp. 83 - 90
Journal Article
Cell Cycle, ISSN 1538-4101, 07/2013, Volume 12, Issue 13, pp. 2084 - 2099
Journal Article
Journal Article
Sarcoma, ISSN 1357-714X, 2017, Volume 2017, pp. 1781087 - 7
The treatment of Ewing sarcoma (ES) in adult patients requires a multidisciplinary approach. Systemic therapy remains an important component of clinical... 
Usage | Ifosfamide | Analysis | Clinical trials | Dosage and administration | Drug therapy | Vincristine | Doxorubicin | Cisplatin | Ewing's sarcoma
Journal Article
Cancer Research, ISSN 0008-5472, 04/2011, Volume 71, Issue 8 Supplement, pp. 2993 - 2993
Journal Article
Acta Clinica Belgica, ISSN 1784-3286, 05/2019, Volume 74, Issue 3, pp. 180 - 188
Background and aim: Vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs) cause significant adverse events including thyroid... 
sunitinib | renal cell carcinoma | thyroid dysfunction | polymorphisms | efflux pumps | ABCB1 | GENOTYPE | CYP3A5 | TYROSINE KINASE INHIBITORS | MEDICINE, GENERAL & INTERNAL | INTERFERON-ALPHA | IMPACT | PHARMACOKINETICS | GENES | SINGLE-NUCLEOTIDE POLYMORPHISMS | EXPOSURE
Journal Article
Acta Clinica Belgica, ISSN 1784-3286, 05/2019, Volume 74, Issue 3, pp. 169 - 179
Objectives: To study the prevalence of hypogonadism in male patients with metastatic renal cell carcinoma (mRCC) starting with targeted therapies and the... 
targeted therapy | fatigue | hypogonadism | Renal cell carcinoma | outcome | PAZOPANIB | EVEROLIMUS | AXITINIB | SECONDARY | PREVALENCE | SORAFENIB | MEDICINE, GENERAL & INTERNAL | INTERFERON-ALPHA | DOUBLE-BLIND | SUNITINIB | TESTOSTERONE LEVELS
Journal Article